StemCells (STEM) reports an initial transplant of neural cells into a patient in its trial for...

|By:, SA News Editor

StemCells (STEM) reports an initial transplant of neural cells into a patient in its trial for dry age-related macular degeneration in Dallas. Shares +6% premarket.